419 related articles for article (PubMed ID: 18052993)
21. [Catecholaminergic polymorphic ventricular tachycardia].
Leren IS; Haugaa KH; Edvardsen T; Anfinsen OG; Kongsgård E; Berge KE; Leren TP; Amlie JP
Tidsskr Nor Laegeforen; 2010 Jan; 130(2):139-42. PubMed ID: 20125202
[TBL] [Abstract][Full Text] [Related]
22. A novel variant in RyR2 causes familiar catecholaminergic polymorphic ventricular tachycardia.
Bosch C; Campuzano O; Sarquella-Brugada G; Cesar S; Perez-Serra A; Coll M; Mademont I; Mates J; Del Olmo B; Iglesias A; Brugada J; Petersen V; Brugada R
Forensic Sci Int; 2017 Jan; 270():173-177. PubMed ID: 27988446
[TBL] [Abstract][Full Text] [Related]
23. Genes, exercise and sudden death: molecular basis of familial catecholaminergic polymorphic ventricular tachycardia.
Laitinen PJ; Swan H; Piippo K; Viitasalo M; Toivonen L; Kontula K
Ann Med; 2004; 36 Suppl 1():81-6. PubMed ID: 15176428
[TBL] [Abstract][Full Text] [Related]
24. A delayed diagnosis of catecholaminergic polymorphic ventricular tachycardia with a mutant of RYR2 at c.7580T>G for 6 years in a 9-year-old child.
Duan H; Lu Y; Yan S; Qiao L; Hua Y; Li Y; Zhou K; Wang C
Medicine (Baltimore); 2018 Apr; 97(16):e0368. PubMed ID: 29668588
[TBL] [Abstract][Full Text] [Related]
25. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.
Priori SG; Napolitano C; Memmi M; Colombi B; Drago F; Gasparini M; DeSimone L; Coltorti F; Bloise R; Keegan R; Cruz Filho FE; Vignati G; Benatar A; DeLogu A
Circulation; 2002 Jul; 106(1):69-74. PubMed ID: 12093772
[TBL] [Abstract][Full Text] [Related]
26. Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients.
Postma AV; Denjoy I; Kamblock J; Alders M; Lupoglazoff JM; Vaksmann G; Dubosq-Bidot L; Sebillon P; Mannens MM; Guicheney P; Wilde AA
J Med Genet; 2005 Nov; 42(11):863-70. PubMed ID: 16272262
[TBL] [Abstract][Full Text] [Related]
27. A novel mutation in FKBP12.6 binding region of the human cardiac ryanodine receptor gene (R2401H) in a Japanese patient with catecholaminergic polymorphic ventricular tachycardia.
Aizawa Y; Ueda K; Komura S; Washizuka T; Chinushi M; Inagaki N; Matsumoto Y; Hayashi T; Takahashi M; Nakano N; Yasunami M; Kimura A; Hiraoka M; Aizawa Y
Int J Cardiol; 2005 Mar; 99(2):343-5. PubMed ID: 15749201
[TBL] [Abstract][Full Text] [Related]
28. Co-Phenotype of Left Ventricular Non-Compaction Cardiomyopathy and Atypical Catecholaminergic Polymorphic Ventricular Tachycardia in Association With R169Q, a Ryanodine Receptor Type 2 Missense Mutation.
Nozaki Y; Kato Y; Uike K; Yamamura K; Kikuchi M; Yasuda M; Ohno S; Horie M; Murayama T; Kurebayashi N; Horigome H
Circ J; 2020 Jan; 84(2):226-234. PubMed ID: 31875585
[TBL] [Abstract][Full Text] [Related]
29. [Catecholaminergic polymorphic ventricular tachycardia is a rare inherited heart disease].
Holst AG; Tfelt-Hansen J; Olesen MS; Theilade J; Winkel BG; Christensen AH; Bundgaard H; Haunsø S; Svendsen JH
Ugeskr Laeger; 2010 Aug; 172(31):2140-4. PubMed ID: 20670590
[TBL] [Abstract][Full Text] [Related]
30. Catecholaminergic polymorphic ventricular tachycardia found in an adolescent after a methylenedioxymethamphetamine and marijuana-induced cardiac arrest.
Diffley M; Armenian P; Gerona R; Reinhartz O; Avasarala K
Crit Care Med; 2012 Jul; 40(7):2223-6. PubMed ID: 22584762
[TBL] [Abstract][Full Text] [Related]
31. Successful treatment of catecholaminergic polymorphic ventricular tachycardia with flecainide: a case report and review of the current literature.
Pott C; Dechering DG; Reinke F; Muszynski A; Zellerhoff S; Bittner A; Köbe J; Wasmer K; Schulze-Bahr E; Mönnig G; Kotthoff S; Eckardt L
Europace; 2011 Jun; 13(6):897-901. PubMed ID: 21292648
[TBL] [Abstract][Full Text] [Related]
32. [Catecholinergic ventricular tachycardia in children].
Denjoy I; Postma A; Lupoglazoff JM; Vaksman G; Kamblock J; Leenhardt A; Wilde AA; Guicheney P
Arch Mal Coeur Vaiss; 2005 May; 98(5):506-12. PubMed ID: 15966600
[TBL] [Abstract][Full Text] [Related]
33. Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia.
Hayashi M; Denjoy I; Extramiana F; Maltret A; Buisson NR; Lupoglazoff JM; Klug D; Hayashi M; Takatsuki S; Villain E; Kamblock J; Messali A; Guicheney P; Lunardi J; Leenhardt A
Circulation; 2009 May; 119(18):2426-34. PubMed ID: 19398665
[TBL] [Abstract][Full Text] [Related]
34. Unusual clinical presentation in a family with catecholaminergic polymorphic ventricular tachycardia due to a G14876A ryanodine receptor gene mutation.
Allouis M; Probst V; Jaafar P; Schott JJ; Le Marec H
Am J Cardiol; 2005 Mar; 95(5):700-2. PubMed ID: 15721128
[TBL] [Abstract][Full Text] [Related]
35. Exon 3 deletion of RYR2 encoding cardiac ryanodine receptor is associated with left ventricular non-compaction.
Ohno S; Omura M; Kawamura M; Kimura H; Itoh H; Makiyama T; Ushinohama H; Makita N; Horie M
Europace; 2014 Nov; 16(11):1646-54. PubMed ID: 24394973
[TBL] [Abstract][Full Text] [Related]
36. Genotypic heterogeneity and phenotypic mimicry among unrelated patients referred for catecholaminergic polymorphic ventricular tachycardia genetic testing.
Tester DJ; Arya P; Will M; Haglund CM; Farley AL; Makielski JC; Ackerman MJ
Heart Rhythm; 2006 Jul; 3(7):800-5. PubMed ID: 16818210
[TBL] [Abstract][Full Text] [Related]
37. A novel early onset lethal form of catecholaminergic polymorphic ventricular tachycardia maps to chromosome 7p14-p22.
Bhuiyan ZA; Hamdan MA; Shamsi ET; Postma AV; Mannens MM; Wilde AA; Al-Gazali L
J Cardiovasc Electrophysiol; 2007 Sep; 18(10):1060-6. PubMed ID: 17666061
[TBL] [Abstract][Full Text] [Related]
38. Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations.
Swan H; Laitinen P; Kontula K; Toivonen L
J Cardiovasc Electrophysiol; 2005 Feb; 16(2):162-6. PubMed ID: 15720454
[TBL] [Abstract][Full Text] [Related]
39. The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis.
Medeiros-Domingo A; Bhuiyan ZA; Tester DJ; Hofman N; Bikker H; van Tintelen JP; Mannens MM; Wilde AA; Ackerman MJ
J Am Coll Cardiol; 2009 Nov; 54(22):2065-74. PubMed ID: 19926015
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
